Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Is the chemotherapy era in advanced non-small cell lung cancer really over? Maybe not yet.
Vesicovaginal fistulas in the developed world: An analysis of disease characteristics, treatments, and complications of surgical repair using the ACS-NSQIP database.
Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors.
RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer.
Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer.
Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer. Curr Oncol Rep. 2016 09; 18(9):59.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Carcinoma, Non-Small-Cell Lung
Cell Cycle Checkpoints
Humans
Immunotherapy
Prognosis
authors with profiles
Marina Chiara Garassino